Kristin C. Peck is the Chief Executive Officer of Zoetis Inc Class A, a leading animal health company. With a robust professional background in the pharmaceutical and animal health industries, Peck has been instrumental in driving Zoetis's growth and success. Before becoming CEO in 2020, she held several key leadership positions within the company, including Chief Financial Officer and Group President of U.S. Operations, Business Development, and Strategy. Her strategic vision and deep understanding of the industry have been pivotal in shaping Zoetis's trajectory. Peck's career began at Pfizer, where she spent nearly two decades in various roles, including Vice President of Strategy and Business Development for Pfizer's Animal Health and Diversified Businesses. Her transition to Zoetis, which was spun off from Pfizer in 2013, marked the beginning of a new chapter in her career. Under her leadership, Zoetis has expanded its global footprint, introduced innovative products, and strengthened its position as a leader in the animal health market. Peck's commitment to advancing animal health through science and technology has earned her recognition and respect within the industry. As CEO of Zoetis, Kristin C. Peck continues to steer the company toward new heights. She oversees a diverse portfolio of products and services that cater to both companion and livestock animals. Her leadership style emphasizes innovation, sustainability, and ethical business practices. Peck is also dedicated to fostering a culture of inclusivity and diversity at Zoetis, believing that a diverse workforce is key to driving creativity and success. Her contributions to the animal health sector and her role in guiding Zoetis's strategic direction underscore her status as a visionary leader in the industry.